| |
 |
|
Class Information
Number: 435/91.31
Name: Chemistry: molecular biology and microbiology > Micro-organism, tissue cell culture or enzyme using process to synthesize a desired chemical compound or composition > Preparing compound containing saccharide radical > Preparing nitrogen-containing saccharide > N-glycoside > Nucleotide > Polynucleotide (e.g., nucleic acid, oligonucleotide, etc.) > Polynucleotide contains only ribonucleotide monomers > Involving catalytic ribonucleic acid
Description: Processes wherein a ribonucleic acid (RNA) acting as an enzyme is involved as a reactant in, or as a product of, a process of synthesizing a polynucleotide containing only ribonucleotide monomers.
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 7625873 |
Antisense antibacterial method and compound |
Dec. 1, 2009 |
| 7622248 |
Ribozymes with broad tRNA aminoacylation activity |
Nov. 24, 2009 |
| 7622453 |
Oligomeric compounds for the modulation of Bcl-2 |
Nov. 24, 2009 |
| 7598369 |
siRNA targeting histamine receptor H1 |
Oct. 6, 2009 |
| 7592442 |
siRNA targeting ribonucleotide reductase M2 polypeptide (RRM2 or RNR-R2) |
Sep. 22, 2009 |
| 7589190 |
Potent LNA oligonucleotides for the inhibition of HIF-1A expression |
Sep. 15, 2009 |
| 7563884 |
Antisense modulation of PTP1B expression |
Jul. 21, 2009 |
| 7563778 |
Antisense oligonucleotide preparation method |
Jul. 21, 2009 |
| 7563601 |
Artificial riboswitch for controlling pre-mRNA splicing |
Jul. 21, 2009 |
| 7560229 |
Methods of use of the enzymes of mycothiol synthesis |
Jul. 14, 2009 |
| 7528117 |
High efficacy antisense RI.sub..alpha.PKA poly-DNP oligoribonucleotides |
May. 5, 2009 |
| 7485468 |
Molecular targets and compounds, and methods to identify the same, useful in the treatment of joint degenerative and inflammatory diseases |
Feb. 3, 2009 |
| 7479369 |
Use of eukaryotic genes affecting spindle formation or microtubule function during cell division for diagnosis and treatment of proliferative diseases |
Jan. 20, 2009 |
| 7462602 |
Anti-scarring ribozymes and methods |
Dec. 9, 2008 |
| 7445891 |
Nucleic acid triggered catalytic drug and probe release |
Nov. 4, 2008 |
| 7422849 |
Method for determining expression of a PI3 kinase gene |
Sep. 9, 2008 |
| 7422902 |
Lipid-nucleic acid particles prepared via a hydrophobic lipid-nucleic acid complex intermediate and use for gene transfer |
Sep. 9, 2008 |
| 7405205 |
Antitumor antisense sequences directed against R1 and R2 components of ribonucleotide reductase |
Jul. 29, 2008 |
| 7399586 |
Modulation of biological signal transduction by RNA interference |
Jul. 15, 2008 |
| 7381708 |
Suppression of eIF5A1 expression by the use of antisense oligonucleotides for the prevention of retinal cell death in the glaucomatous eye |
Jun. 3, 2008 |
| 7345025 |
Methods for genetic modification of hematopoietic progenitor cells and uses of the modified cells |
Mar. 18, 2008 |
| 7332335 |
Decreasing cell proliferation by decreasing levels of PP5 |
Feb. 19, 2008 |
| 7297488 |
Identifying and testing antisense oligonucleotides that inhibit telomerase reverse transcriptase |
Nov. 20, 2007 |
| 7294713 |
Antisense IAP oligonucleotides and uses thereof |
Nov. 13, 2007 |
| 7217572 |
Modulation of HIF1.alpha. and HIF2.alpha. expression |
May. 15, 2007 |
| 7186530 |
Protein associated with cell stress response |
Mar. 6, 2007 |
| 7179593 |
Estrogen receptor site-specific ribozymes and uses thereof for estrogen dependent tumors |
Feb. 20, 2007 |
| 7179796 |
Antisense modulation of PTP1B expression |
Feb. 20, 2007 |
| 7148044 |
Nucleic acid enzyme for RNA cleavage |
Dec. 12, 2006 |
| 7144999 |
Modulation of hypoxia-inducible factor 1 alpha expression |
Dec. 5, 2006 |
| 7141665 |
Enzymatic DNA molecules |
Nov. 28, 2006 |
| 7138378 |
Genetic suppression and replacement |
Nov. 21, 2006 |
| 7135312 |
Circular DNA vectors for synthesis of RNA and DNA |
Nov. 14, 2006 |
| 7074601 |
Nucleozymes |
Jul. 11, 2006 |
| 7041817 |
Synthesis, deprotection, analysis and purification of RNA and ribozymes |
May. 9, 2006 |
| 6916653 |
Ribozymal nucleic acid |
Jul. 12, 2005 |
| 6869780 |
Nodavirus-like DNA expression vector and uses therefor |
Mar. 22, 2005 |
| 6867039 |
Antisense modulation of dual specific phosphatase 5 expression |
Mar. 15, 2005 |
| 6858590 |
Vaccines containing ribavirin and methods of use thereof |
Feb. 22, 2005 |
| 6849612 |
Oligonucleotide modulation of cell adhesion |
Feb. 1, 2005 |
| 6841541 |
Regulation of BCL-2-gene expression |
Jan. 11, 2005 |
| 6828139 |
Production of replicative hepatitis C virus |
Dec. 7, 2004 |
| 6828148 |
Miniribozymes active at low magnesium ion concentrations |
Dec. 7, 2004 |
| 6828151 |
Antisense modulation of hematopoietic cell protein tyrosine kinase expression |
Dec. 7, 2004 |
| 6822139 |
Modulation of storage organs |
Nov. 23, 2004 |
| 6818447 |
Method and reagent for the treatment of diseases or conditions related to levels of vascular endothelial growth factor receptor |
Nov. 16, 2004 |
| 6818209 |
Retroviral delivery system |
Nov. 16, 2004 |
| 6803194 |
Use of ribozymes for functionating genes |
Oct. 12, 2004 |
| 6803360 |
Compositions and methods for reducing radiation and drug resistance in cells |
Oct. 12, 2004 |
| 6790827 |
Bioconjugates and delivery of bioactive agents |
Sep. 14, 2004 |
|
|
|
